NCT00177099 is a Phase 1 clinical trial of FK506, GP11046, GP11511 in Alopecia, sponsored by Hordinsky, Maria K., MD.

Who is sponsoring NCT00177099?

NCT00177099 is sponsored by Hordinsky, Maria K., MD.

What drugs are being tested in NCT00177099?

Interventions in NCT00177099: FK506, GP11046, GP11511.

Is NCT00177099 still recruiting?

NCT00177099 is currently completed. Last updated 8 November 2006.

Last reviewed 2006-11-08 · How we verify

NCT00177099

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Neurotrophic Effects of Immunophilin Ligands on Human Hair Follicles Grafted Onto Service Combined Immunodeficient (SCID) Mice

Completed Phase 1 Last updated 8 November 2006

What this trial tests

Phase 1 trial testing FK506, GP11046, GP11511 in Alopecia in 35 participants. Completed in 1 September 2004.

Timeline

1 July 2003

1 September 2004

Quick facts

Lead sponsor	Hordinsky, Maria K., MD
Phase	Phase 1
Status	Completed
Study type	INTERVENTIONAL
Allocation	non randomized
Design	factorial
Masking	none
Primary purpose	treatment
Enrollment	35
Start date	1 July 2003
Estimated completion	1 September 2004
Sites	1 location across United States

Drugs / interventions tested

FK506, GP11046, GP11511 — full drug profile →

Conditions studied

Alopecia — all drugs for Alopecia →

Sponsor

Hordinsky, Maria K., MD — full company profile →

Who can join

Adults 18 to 65, male only, with Alopecia. Healthy volunteers can join.

What's being measured

Primary outcomes are the specific endpoints the trial is designed to prove or disprove.

The average number of terminal hairs per graft will be compared between the control and the treated group.

Sponsor's own description

The purpose of this study is to determine if immunophilin ligands may have the potential to reverse hair loss.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Alopecia

Currently open trials in the same condition.

NCT07422376 — Evaluation of Scalp Cooling During Chemotherapy on Quality of Life and the Potential Role of Single Nucleotide Variation · NA · recruiting
NCT07107841 — Autologous Hair Follicle Secretome for Androgenic Alopecia (Single Site) · NA · recruiting
NCT06998680 — 6-Month Trial of Chinese Herbal Treatments for Hair Loss and Gray Hair · NA · recruiting
NCT05484973 — Study to Assess the Ability of the Portable Scalp Cooling System (PSCS) to Prevent Hair Loss · NA · recruiting
NCT06215469 — Portable Scalp Cooling System (PSCS) to Prevent Hair Loss for Breast Cancer Patients (Cooler Heads) · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT00177099 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Hordinsky, Maria K., MD
Last refreshed: 8 November 2006

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT00177099.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing